Robuta

Press release - Global Market Estimates Research & Consultants - Lysosomal Acid Lipase Deficiency Treatment Market Report - published on openPR.com

Clinical findings of hepatomegaly and splenomegaly, the abnormal enlargement of the liver and spleen, respectively, should prompt a broad differential...

https://www.youtube.com/watch?v=nvvTn3Hnrc0

Inhibiyiton of the lysosomal chloride-proton antiporter ClC-7 by the signaling lipid PI(3,5)P2 is important for lysosomal pH maintenance and is disrupted by a...

5'-3' exonuclease PLD31,2-ETHANEDIOL2-acetamido-2-deoxy-beta-D-glucopyranoseMAGNESIUM IONMANGANESE (II) IONPHOSPHATE IONSULFATE...

Press release - MRRSE - Lysosomal Storage Diseases Therapeutics Market Projected to Reflect at 10% CAGR by 2026 - published on openPR.com

1H3 Fab heavy chain1H3 Fab light chainGlycosylated lysosomal membrane protein2-acetamido-2-deoxy-beta-D-glucopyranoseSODIUM ION

Non-small cell lung cancer (NSCLC) patients carrying an epidermal growth factor receptor (EGFR) mutation are initially sensitive to EGFR-tyrosine kinase...

Monoclonal gammopathies are frequently complicated by kidney lesions that increase the disease morbidity and mortality. In particular, abnormal Ig free light...

scientific article published on 01 May 1964

The global lysosomal storage disease treatment market size was estimated at USD 4.54 billion in 2024 and is projected to reach USD 6.68 billion by 2033,...

Alpha-galactosidase A2-acetamido-2-deoxy-beta-D-glucopyranosealpha-D-galactopyranosealpha-D-mannopyranosebeta-D-mannopyranose

Lysosomal storage disorders (LSD) are characterized by the accumulation of diverse lipid species in lysosomes. Niemann-Pick type A/B (NPA/B) and type C disea...